tiprankstipranks
CENTOGENE Shareholders Approve Key Resolutions
Company Announcements

CENTOGENE Shareholders Approve Key Resolutions

Centogene NV (CNTG) has released an update.

Don't Miss Our Christmas Offers:

CENTOGENE N.V., a key player in providing data-driven solutions for rare and neurodegenerative diseases, has successfully concluded its 2024 Annual General Meeting with all proposed resolutions passed by shareholders. Key approvals included the adoption of a new supervisory board compensation structure, reappointment of Ernst & Young Accountants LLP as external auditor, and extended powers for the management board concerning share issuance and acquisition. The company continues to leverage its extensive biodatabank and multiomic technologies to support precision medicine and collaborate with over 50 pharma partners.

For further insights into CNTG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCentogene NV Announces Nasdaq Delisting
TheFlyCentogene receives delisting notice from Nasdaq
TheFlyCentogene publishes ROPAD study data on Parkinson’s disease in Brain
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App